Eva Nabulime

Statistics

Publications

Citations

132

H-Index

Active since

2017

Affiliations

Joint Clinical Research Centre(Current)

University College London

Western University

Makerere University

Case Western Reserve University

Eva Nabulime is an author at Joint Clinical Research Centre specializing in antiretroviral therapy, antiviral therapy, and nucleoside reverse transcriptase inhibitors.

Publications per year

2017–2020

Publications

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda

Emmanuel Ndashimye, Mariano Avino, Fred Kyeyune et al. · AIDS Research and Human Retroviruses · 2018 · 26 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda

Alisen Ayitewala, Fred Kyeyune, Pamela Ainembabazi et al. · AIDS Research and Therapy · 2020 · 20 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

Felicity Fitzgerald, Édouard Lhomme, Kathryn Harris et al. · The Journal of Infectious Diseases · 2018 · 17 citations · Full text

Life Sciences, Immunology, Microbiology +10

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries

Richard M. Gibson, Gabrielle Nickel, Fred Kyeyune et al. · Infectious Diseases of Poverty · 2017 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 6